miRNA-221 and miRNA-483-3p Dysregulation Correlated with Poor Survival in Esophageal Adenocarcinoma
Authors:
- Isotta BozzarelliIBIsotta Bozzarelli
- Federica IsidoriFIFederica Isidori
- Arianna OrsiniAOArianna Orsini
- Luca MastracciLMLuca Mastracci
- Deborah MalviDMDeborah Malvi
- Marialuisa LugaresiMLMarialuisa Lugaresi
- Silvia FittipaldiSFSilvia Fittipaldi
- Henna SoderstromHSHenna Soderstrom
- Jari RäsänenJRJari Räsänen
- Antonietta D'ErricoADAntonietta D'Errico
- Anna TomezzoliATAnna Tomezzoli
- Riccardo RosatiRRRiccardo Rosati
Preprint
- 11 December 2023
- preprint
- Published by MDPI AG in Preprints.org
Abstract
Alterations in microRNA (miRNA) expression have been reported in different cancers. We assessed the expression of 754 oncology-related miRNAs in esophageal adenocarcinoma (EAC) and evaluated their correlations with clinical parameters. We found that miR-221 and 483-3p were consistently upregulated in EAC cases vs. controls (Wilcoxon signed rank test: miR-221 P<0.0001; miR-483-3p P<0.0001). Kaplan‒Meier analysis showed worse cancer-related survival in patients expressing high miR-221 or miR-483-3p levels in all EACs (log-rank P=0.0025 and P=0.0235, respectively). Higher miR-221 or miR-483-3p levels also correlated with advanced tumor stages (Mann‒Whitney P=0.0195 and P=0.0085, respectively). Moreover, we found that overexpression of miR-221 was associated with worse survival in the low-risk EAC group. A significantly worse outcome was associated with the combined overexpression of miR-221 and miR-483-3p (log-rank P=0.0410). To identify target genes modified by miRNAs, we evaluatedtheir expression in different EAC cell lines, we transfected the corresponding mimic RNA (miRVANA) for either miR-221 or miR-483-3p and performed RNA-seq analysis. We found converging dysregulated genes involved in cancer progression, apoptosis, ATP synthesis and angiogenesis in miRNA-overexpressing cell lines, including a long non-coding RNA associated with oncogenesis, i.e., MALAT1. In conclusion, miR-221 and 483-3p overexpression in EAC correlated with low cancer-related survival, indicating that they might be considered new biomarkers for patient stratification.Keywords
All Related Versions
- Version 1, 2023-12-11, Preprints
- Published version: Cancers, 16 (3), 591.
This publication has 60 references indexed in Scilit:
- Transcriptomic profiling reveals three molecular phenotypes of adenocarcinoma at the gastroesophageal junctionInternational Journal of Cancer, 2019
- The prognostic and potentially predictive value of the Laurén classification in oesophageal adenocarcinomaEuropean Journal of Cancer, 2017
- Cancer of the Esophagus and Esophagogastric Junction: An Eighth Edition Staging PrimerJournal of Thoracic Oncology, 2017
- MicroRNA and cancer – A brief overviewAdvances in Biological Regulation, 2015
- MicroRNAs as therapeutic targets in human cancersWIREs RNA, 2014
- Esophagogastric Metaplasia Relates to Nodal Metastases in Adenocarcinoma of Esophagus and CardiaThe Annals of Thoracic Surgery, 2013
- MicroRNA expression profiles of esophageal cancerThe Journal of Thoracic and Cardiovascular Surgery, 2008
- Immunopathological Patterns of the Stomach in Adenocarcinoma of the Esophagus, Cardia, and Gastric Antrum: Gastric Profiles in Siewert Type I and II TumorsThe Annals of Thoracic Surgery, 2007
- Risk of tumorigenesis in overgrowth syndromes: A comprehensive reviewAmerican Journal of Medical Genetics Part C: Seminars in Medical Genetics, 2005
- Identification of human fetal liver miRNAs by a novel methodFEBS Letters, 2005